1-11 of 11
Adrienne de Labarthe
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia

Clinical Trials & Observations
Guillaume Olombel, Estelle Guerin, Julien Guy, Jean-Yves Perrot, Florent Dumezy, Adrienne de Labarthe, Jean-Noël Bastie, Ollivier Legrand, Emmanuel Raffoux, Adriana Plesa, Orianne Wagner-Ballon, Edouard Cornet, Véronique Salaun, Claude Preudhomme, Xavier Thomas, Cécile Pautas, Sylvain Chantepie, Pascal Turlure, Sylvie Castaigne, Hervé Dombret, Jean Feuillard
Journal: Blood
Blood (2016) 127 (17): 2157–2160.
https://doi.org/10.1182/blood-2016-01-689976
Published: 2016
Includes: Supplemental data
Journal Articles

Assessment Of Minimal Residual Disease In Acute Myeloblastic Leukemia In Multiparameter Flow Cytometry

Francis Lacombe, Kaoutar Allou, Christine Arnoulet, Pharm. D., Lydia Campos, MD, PhD, Adrienne de Labarthe, Florent Dumezy, MD, Jean Feuillard, Franck Genevieve, MD, PhD, Estelle Guerin, Julien Guy, Hélène Jouault, Pascale Lepelley, MD, Marc Maynadie, MD, PhD, Francoise Solly, Orianne Wagner Ballon, Claude Preudhomme, Andre Baruchel, MD, PhD, Herve Dombret, MD, PhD, Norbert Ifrah, MD, Marie C. Béné, PharmSciD, PhD
Journal: Blood
Blood (2013) 122 (21): 2613.
https://doi.org/10.1182/blood.V122.21.2613.2613
Published: 2013
Journal Articles

Do Early Events Excluding Patients with Acute Promyelocytic Leukemia (APL) From Trial Enrollment Modify Treatment Result Evaluation? Real-Life Management of 100 Patients Referred to the University Hospital Saint-Louis Between 2000 and 2010.

Jean-Baptiste Micol, Emmanuel Raffoux, MD, Nicolas Boissel, MD, PhD, Etienne Lengliné, MD, Emmanuel Canet, Thierry Leblanc, Marie-Thérèse Daniel, Adrienne de Labarthe, Odile Maarek, Bruno Cassinat, Christine Chomienne, MD, PhD, Lionel Adès, André Baruchel, Laurent Degos, Elie Azoulay, MD, PhD, Hervé Dombret
Journal: Blood
Blood (2010) 116 (21): 1083.
https://doi.org/10.1182/blood.V116.21.1083.1083
Published: 2010
Journal Articles

Long-Term Results of the Imatinib GRAAPH-2003 Study in Newly-Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia..

Aline Tanguy-Schmidt, MD, Adrienne de Labarthe, Philippe Rousselot, MD, PhD, Francoise Huguet, Eric Delabesse, PhD, Francis Witz, MD, Sebastien Maury, MD, PhD, Delphine Rea, MD, PhD, Jean-Michel Cayuela, MD, Marie-Christiane M Vekemans, Reman Oumédaly, Agnes Buzyn, Arnaud Pigneux, MD, PhD, Martine Escoffre, Yves Chalandon, Elizabeth Macintyre, MD, PhD, Jean-Paul Vernant, Xavier Thomas, MD, PhD, Norbert Ifrah, MD, Herve Dombret, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3080.
https://doi.org/10.1182/blood.V114.22.3080.3080
Published: 2009
Journal Articles

Epigenetic Therapy with 5-Azacitidine, Valproic Acid, and ATRA in Patients with High-Risk AML or MDS: Results of the French VIVEDEP Phase II Study

Emmanuel Raffoux, Adrienne de Labarthe, Audrey Cras, Christian Recher, Pascal Turlure, Jean-Pierre Marolleau, Oumedaly Reman, Claude Gardin, Sebastien Maury, Philippe Rousselot, Jean-Valère Malfuson, Odile Maarek, Laurent Degos, Christine Chomienne, Hervé Dombret
Journal: Blood
Blood (2008) 112 (11): 763.
https://doi.org/10.1182/blood.V112.11.763.763
Published: 2008
Journal Articles

Intensive Consolidation with Clofarabine and Intermediate-Dose Cytarabine (CLARA) in Patients with High-Risk AML in First CR: The ALFA-0702 Pilot Study.

Xavier Thomas, Ida Lobe, Emmanuel Raffoux, Nicolas Boissel, Quoc-Hung Le, Franck Nicolini, Adrienne de Labarthe, Sandrine Hayette, Jean-Michel Cayuela, Hervé Dombret
Journal: Blood
Blood (2008) 112 (11): 1934.
https://doi.org/10.1182/blood.V112.11.1934.1934
Published: 2008
Journal Articles

Feasibility and Safety Profile of Intensive Consolidation with Clofarabine and Intermediate-Dose Cytarabine (CLARA) in Younger Patients with AML in First Complete Remission (AML-CR1).

Ida Lobe, Nicolas Boissel, Emmanuel Raffoux, Adrienne de Labarthe, Cécile Pautas, Stéphane de Botton, Xavier Thomas, Hervé Dombret
Journal: Blood
Blood (2007) 110 (11): 1853.
https://doi.org/10.1182/blood.V110.11.1853.1853
Published: 2007
Journal Articles

Autologous Hematopoietic Stem Cell Collection and Transplantation in Acute Myeloid Leukemia Patients in Second Remission after Treatment with Fractionated Gentuzumab Ozogamycin.

Delphine Rea, MD, PhD, Emmanuel Raffoux, MD, Anne Laure Taksin, MD, Adrienne De Labarthe, MD, Nicolas Boissel, MD, Jean Michel Miclea, MD, Sylvie Castaigne, MD, Herve Dombret, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5211.
https://doi.org/10.1182/blood.V108.11.5211.5211
Published: 2006
Journal Articles

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study

Clinical Trials & Observations
Adrienne de Labarthe, Philippe Rousselot, Françoise Huguet-Rigal, Eric Delabesse, Francis Witz, Sébastien Maury, Delphine Réa, Jean-Michel Cayuela, Marie-Christine Vekemans, Oumedaly Reman, Agnès Buzyn, Arnaud Pigneux, Martine Escoffre, Yves Chalandon, Elizabeth MacIntyre, Véronique Lhéritier, Jean-Paul Vernant, Xavier Thomas, Norbert Ifrah, Hervé Dombret, for the Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)
Journal: Blood
Blood (2006) 109 (4): 1408–1413.
https://doi.org/10.1182/blood-2006-03-011908
Published: 2006
Includes: Supplemental data
Journal Articles

Few Genes Expression Predicts Outcome in Adult Acute Myeloid Leukemia (AML) with Normal Karyotype.

Nicolas Boissel, Valeria Biggio, Aline Renneville, Nathalie Philippe, Jean-Michel Cayuela, Selim Corm, Emmanuel Raffoux, Stephane de Botton, Adrienne de Labarthe, Pierre Fenaux, Hervé Dombret, Claude Preudhomme
Journal: Blood
Blood (2005) 106 (11): 332.
https://doi.org/10.1182/blood.V106.11.332.332
Published: 2005
Journal Articles

Sequential Treatment with 5-Azacytidine, Valproic Acid (VPA), and All-Trans Retinoic Acid (ATRA) in Patients with High-Risk Acute Myeloid Leukemia (AML).

Emmanuel Raffoux, Adrienne de Labarthe, Claude Gardin, Marie-Therese Daniel, Christine Chomienne, Pierre Fenaux, Laurent Degos, Herve Dombret
Journal: Blood
Blood (2005) 106 (11): 2798.
https://doi.org/10.1182/blood.V106.11.2798.2798
Published: 2005